A Resource for Healthcare and Social Services Professionals
Attend a free live training event! Browse trainings by topic, month, or event format (virtual or in-person), and then be sure to register online. Please note this list of upcoming trainings is updated regularly. If you do not see a specific training listed below, please check back or email us with any questions. If you want to be notified of newly booked trainings, subscribe to our mailing list.
DEA-eligible
Topic: ECHO
As part of the twice-monthly MA OBAT ECHO® series, Judith Austin, MSN, PMHNP-BC, CARN-AP, will discuss how to strengthen interdisciplinary collaboration in the assessment and treatment of psychiatric conditions among people with co-occurring substance use disorders (SUD); review common psychiatric disorders and clinical presentations encountered in people with SUD; and explain how to apply evidence-informed principles for initiating, monitoring, and educating patients about commonly prescribed psychiatric medications in the context of SUD. The didactic session will be followed by a de-identified patient case presentation from an ECHO® participant, along with recommendations from the panel of experts and attendees.
![]() |
Tuesday, 11/10/2026 7:30 am – 9:00 am ET |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: ECHO
As part of the twice-monthly SUD Care Continuum ECHO® series, Michael Lynch, MD, FACMT, will discuss interdisciplinary strategies for identifying and responding to emerging drug supply adulterants such as medetomidine across clinical and harm reduction settings; describe the emerging role of medetomidine in the illicit drug supply, including its pharmacologic effects and associated clinical risks; and review clinical approaches to recognizing and managing suspected medetomidine exposure, including overdose response, withdrawal considerations, and linkage to ongoing care. The didactic will be followed by a de-identified patient case presentation from an ECHO® participant and recommendations from the panel of experts and attendees.
![]() |
Wednesday, 11/18/2026 12:00 pm – 1:15 pm ET |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: ECHO
As part of the twice-monthly MA OBAT ECHO® series, Stephen Holt, MD, MS, FACP, FASAM, will discuss the identification, assessment, and management of alcohol withdrawal syndrome (AWS) in outpatient settings, including clinical features and risk factors that inform severity and level-of-care decisions. The presentation will also cover evidence-informed management strategies, including pharmacotherapy, criteria for escalation of care, and interdisciplinary coordination to support safe and effective patient care. The didactic session will be followed by a de-identified patient case presentation from an ECHO® participant, along with recommendations from the panel of experts and attendees.
![]() |
Tuesday, 12/1/2026 7:30 am – 9:00 am ET |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: ECHO
As part of the twice-monthly SUD Care Continuum ECHO® series, Megan Hudson, MSN, PMHNP-BC, will differentiate substance-induced psychosis from primary psychotic disorders using clinical history, symptom characteristics, and the temporal relationship between substance use and psychotic symptoms. She will also review evidence-informed approaches to assessment, treatment planning, follow-up, and interdisciplinary care coordination for patients with co-occurring psychosis and substance use disorders. The didactic will be followed by a de-identified patient case presentation from an ECHO® participant and recommendations from the panel of experts and attendees.
![]() |
Wednesday, 12/2/2026 12:00 pm – 1:15 pm ET |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: ECHO
As part of the twice-monthly SUD Care Continuum ECHO® series, Judith Austin, PMHNP, CARN-AP, will strengthen interdisciplinary collaboration in the assessment and treatment of psychiatric conditions among people with co-occurring substance use disorders, and identify common psychiatric disorders and clinical presentations encountered in people with substance use disorders. She will also apply evidence-informed principles for initiating, monitoring, and educating patients about commonly prescribed psychiatric medications in the context of substance use disorders. The didactic will be followed by a de-identified patient case presentation from an ECHO® participant and recommendations from the panel of experts and attendees.
![]() |
Wednesday, 12/16/2026 12:00 pm – 1:15 pm ET |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: ECHO
As part of the twice-monthly MA OBAT ECHO® series, Gabrielle Simons, MS, RD, LDN, will describe the relationship between substance use, nutritional status, and common nutritional deficiencies, as well as interdisciplinary approaches to addressing nutritional needs as part of comprehensive substance use disorder care. She will also review practical strategies for identifying nutritional concerns and connecting patients with appropriate nutritional and medical supports. The didactic session will be followed by a de-identified patient case presentation from an ECHO® participant, along with recommendations from the panel of experts and attendees.
![]() |
Tuesday, 12/22/2026 7:30 am – 9:00 am ET |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: ECHO
As part of the twice-monthly SUD Care Continuum ECHO® series, Robert Lowe, MD, will discuss key risk factors, clinical features, and stages of alcohol-related liver disease relevant to addiction treatment settings. He will also review evidence-informed strategies for screening, assessment, treatment, and referral, including interdisciplinary coordination in the identification and management of alcohol-related liver disease among patients with alcohol use disorder. The didactic will be followed by a de-identified patient case presentation from an ECHO® participant and recommendations from the panel of experts and attendees.
![]() |
Wednesday, 1/6/2027 12:00 pm – 1:15 pm ET |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: ECHO
As part of the twice-monthly MA OBAT ECHO® series, Michael Lynch, MD, FACEP, FACMT, will develop interdisciplinary strategies for identifying and responding to emerging drug supply adulterants such as medetomidine across clinical and harm reduction settings and describe the emerging role of medetomidine in the illicit drug supply, including its pharmacologic effects and associated clinical risks. He will also apply clinical approaches to recognizing and managing suspected medetomidine exposure, including overdose response, withdrawal considerations, and linkage to ongoing care. The didactic session will be followed by a de-identified patient case presentation from an ECHO® participant, along with recommendations from the panel of experts and attendees.
![]() |
Tuesday, 1/12/2027 7:30 am – 9:00 am ET |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: ECHO
As part of the twice-monthly SUD Care Continuum ECHO® series, Julia Calandra, PharmD, BCACP, will develop interdisciplinary models of low-barrier hepatitis C care that improve coordination between addiction treatment, medical, and harm reduction services and describe principles of low-barrier, person-centered hepatitis C care and their role in reducing disparities among people who use substances. She will also apply practical strategies for integrating hepatitis C screening and treatment into addiction medicine and harm reduction settings, including models such as group care. The didactic will be followed by a de-identified patient case presentation from an ECHO® participant and recommendations from the panel of experts and attendees.
![]() |
Wednesday, 1/20/2027 12:00 pm – 1:15 pm ET |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: ECHO
As part of the twice-monthly MA OBAT ECHO® series, Megan Hudson, MSN, PMHNP-BC, will improve interdisciplinary assessment and care coordination for patients presenting with psychosis in the context of substance use and differentiate substance-induced psychosis from primary psychotic disorders using clinical history, symptom characteristics, and the temporal relationship between substance use and psychotic symptoms. She will also apply evidence-informed approaches to assessment, treatment planning, and follow-up for patients with co-occurring psychosis and substance use disorders. The didactic session will be followed by a de-identified patient case presentation from an ECHO® participant, along with recommendations from the panel of experts and attendees.
![]() |
Tuesday, 1/26/2027 7:30 am – 9:00 am ET |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |